MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.
There was plenty of chatter in medtech during the last month, with medical device heavyweight Medtronic (NYSE:MDT) leading the way as the most-talked about company in the space, with regulatory wins at home and abroad, progress in patent infringement and product liability lawsuits and more.
Massachusetts medical device maker Covidien (NYSE:COV) jumped up to the 2nd-place spot, with just a couple of big headlines about a spat with Johnson & Johnson (NYSE:JNJ) and a hernia mesh product that’s hit some hard time.
Boston Scientific (NYSE:BSX) followed close behind a clutch of stories surrounding some dramatic turns surrounding the 2013 conference of the American College of Cardiologists.
Aesthetics devices maker Allergan (NYSE:AGN) took the 4th spot with news of an upcoming FDA panel date, and healthcare giant Johnson & Johnson rounded out the top 5 with high-profile lawsuits, financial shifts an FDA panel date and a stealthy acquisition.
Medtronic
- FDA warns doc on CoreValve heart implant trial record-keeping issues
- Medtronic lands another EU win for Resolute Integrity stent
- Medtronic pays $84M in damages for Edwards TAVI patent infringement
- Premier strikes CRM deals with Medtronic, Boston Scientific, others
- Medtronic lands EU approval for Attain Performa CRT-D leads
- ACC.13 Roundup: A big week for Medtronic’s Symplicity high blood pressure device
- Medtronic seeks to claw back $10M patent lawsuit loss
- Medtronic CFO: CRM market has a new baseline
- The Medtronic Foundation launches its "Save a Life" campaign with the Timberwolves’ Ricky Rubio
- Report: Medtronic may offer $3B in bonds in 2013
- Lawyer foresees 100s more claims against Medtronic in Infuse lawsuits
Covidien
- Hernia: Covidien’s biologic mesh product hits a wall
- Covidien wins $177M from Johnson & Johnson’s Ethicon Endo-Surgery in ultrasound scalpel spat
Boston Scientific
- Premier strikes CRM deals with Medtronic, Boston Scientific, others
- Boston Scientific hesitates to release full safety results for Watchman heart implant
- Boston Scientific to present full safety results for Watchman heart implant
- Report: Boston Scientific issues alert on its lead-free S-ICD defibrillator
- Boston Scientific’s Watchman heart implant shows improved safety profile in preliminary results
- Boston Scientific apologizes for embargo breach that got its Watchman trial pulled from conference
- ACC defends cancellation as docs lament missing Boston Scientific presentation
- OrbusNeich takes Boston Scientific patent row to Ireland
- Abbott accuses Boston Scientific of poaching stent sales VP, reps
Allergan
Johnson & Johnson
- J&J mesh lawsuit penalty grows to $11.1M
- Closing arguments in DePuy ASR lawsuit
- Venezuelan currency shift lowers Johnson & Johnson’s Q1 outlook
- Jury deems J&J’s DePuy ASR XL hip implant defective in design, orders $8.3M in damages
- J&J’s Cordis snaps up Flexible Stenting Solutions
- J&J faces 2nd trial in in recalled hip controversy
- Ethicon lands FDA nod for cordless Enseal G2 tissue sealer
- Covidien wins $177M from Johnson & Johnson’s Ethicon Endo-Surgery in ultrasound scalpel spat